A total of 29 breast cancer subjects and 7 healthy cancer-free subjects undergoing breast reduction surgery were included. Healthy subjects are indicated by NML (normal) under the histologic grade column.
| Histologic grade (IDC) | Distance to IDC (mm) | Nuclear grade (DCIS) | Distance to DCIS (mm) | Age | Tumor tissue/healthy tissue size (cm) |
| 1 | 6 | — | — | 41 | 0.4 by 0.3 by 0.3 |
| 1 | 1 | — | — | 69 | 1.2 by 1.0 by 0.6 |
| 1 | 1 | I | 1 | 75 | 0.8 by 0.5 by 0.4 |
| 1 | 3 | I | 3 | 65 | 0.8 by 0.6 by 0.5 |
| 1 | 1.6 | II | 5 | 46 | 3.7 by 2.0 by 2.0 |
| 1 | 6 | II | >10 | 70 | 1.6 by 1.1 by 0.8 |
| 2 | 5 | — | — | 75 | 1.5 by 1.3 by 1.2 |
| 2 | 50 | — | — | 71 | 2.1 by 1.5 by 0.9 |
| 2 | 1.3 | — | 8 | 37 | 1.8 by 1.5 by 1.3 |
| 2 | 10 | — | — | 48 | 1.0 by 1.0 by 0.9 |
| 2 | 8 | I–II | >10 | 70 | 2.6 by 4.6 by 0.5 |
| 2 | 14 | II | 17 | 59 | Not grossly identified |
| 2 | 3 | II | 1 | 75 | 1.5 by 1.0 by 0.6 |
| 2 | 6 | II | 10 | 50 | 1.1 by 1.0 by 0.4 |
| 2 | 10 | II | 10 | 67 | 5.2 by 3.3 by 2.4 |
| 2 | 12 | II | 14 | 54 | 1.5 by 1.2 by 1.1 |
| 2 | 51 | II | 51 | 82 | 1.7 by 1.5 by 1.3 |
| 2 | 11 | II | 14 | 57 | 1.5 by 1.4 by 1.0 |
| 2 | 8 | II | 2 | 60 | 1.2 by 0.8 by 0.8 |
| 2 | 6.2 | II | 6.3 | 68 | 1.0 by 1.0 by 0.8 |
| 2 | 25 | II | 25 | 48 | 1.5 by 1.2 by 0.7 |
| 2 | 10 | III | 10 | 51 | 1.1 by 0.9 by 0.8 |
| 2 | 1 | III | no | 67 | 2.0 by 2.0 by 1.8 |
| 3 | 10 | III | 1.2 | 64 | 0.8 by 0.6 by 0.5 |
| 3 | 12 | III | 12 | 76 | 1.9 by 1.8 by 1.7 |
| 3 | 10 | III | 10 | 62 | 2.0 by 1.3 by 1.0 |
| 3 | 5 | III | 0 (positive) | 75 | 2.5 by 2.4 by 2.2 |
| 3 | 4 | — | — | 52 | 2.1 by 1.2 by 1.1 |
| 3 | 1 | — | — | 68 | 1.7 by 1.1 by 1.0 |
| NML | — | — | — | 41 | 15 by 14 by 5.5 |
| NML | — | — | — | 50 | 19 by 16 by 9.0 |
| NML | — | — | — | 45 | 6.5 by 4.1 by 1.1 |
| NML | — | — | — | 70 | 18 by 15 by 8.5 |
| NML | — | — | — | 19 | 9.0 by 4.3 by 3.2 |
| NML | — | — | — | 50 | 15 by 12 by 12 |
| NML | — | — | — | 40 | 14 by 13 by 4.5 |